Dosage and Format
Each bottle contains 60 capsules, each containing 250 mg of Beta-Nicotinamide Mononucleotide (NMN). Recommended dosage: take 1–2 capsules daily with water, or as advised by a healthcare professional.
Formulation Details
Each gelatin capsule provides:
-
Beta-Nicotinamide Mononucleotide (250 mg) – a stable, bioavailable precursor to NAD⁺ (nicotinamide adenine dinucleotide)
Mechanism of Action and Health Applications
NMN is a direct precursor to NAD⁺, a critical coenzyme involved in mitochondrial function, energy metabolism, DNA repair, and cellular signaling. NAD⁺ levels naturally decline with age, contributing to reduced cellular efficiency and various age-associated physiological impairments. Supplementation with NMN has been shown in preclinical and early human studies to increase NAD⁺ levels, thereby supporting healthy aging, metabolic function, and cellular resilience.
Target Population
NMN is particularly recommended for individuals over the age of 40, when endogenous NAD⁺ production begins to decrease significantly. It may also benefit individuals seeking to support cognitive function, metabolic health, and cellular longevity.
Safety and Tolerability
NMN is generally well-tolerated when taken at recommended dosages. No significant adverse effects have been reported in clinical trials. Individuals with underlying medical conditions or those taking medications should consult a healthcare provider before use.
